ID   SYY_GEOSE               Reviewed;         419 AA.
AC   P00952;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   07-JAN-2015, entry version 106.
DE   RecName: Full=Tyrosine--tRNA ligase;
DE            EC=6.1.1.1;
DE   AltName: Full=Tyrosyl-tRNA synthetase;
DE            Short=TyrRS;
GN   Name=tyrS;
OS   Geobacillus stearothermophilus (Bacillus stearothermophilus).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Geobacillus.
OX   NCBI_TaxID=1422;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6840095; DOI=10.1111/j.1432-1033.1983.tb07374.x;
RA   Winter G., Koch G.L.E., Hartley B.S., Barker D.G.;
RT   "The amino acid sequence of the tyrosyl-tRNA synthetase from Bacillus
RT   stearothermophilus.";
RL   Eur. J. Biochem. 132:383-387(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-11.
RX   PubMed=3525162; DOI=10.1111/j.1432-1033.1986.tb09783.x;
RA   Waye M.M.Y., Winter G.;
RT   "A transcription terminator in the 5' non-coding region of the tyrosyl
RT   tRNA synthetase gene from Bacillus stearothermophilus.";
RL   Eur. J. Biochem. 158:505-510(1986).
RN   [3]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=6315404;
RA   Waye M.M.Y., Winter G., Wilkinson A.J., Fersht A.R.;
RT   "Deletion mutagenesis using an 'M13 splint': the N-terminal structural
RT   domain of tyrosyl-tRNA synthetase (B. stearothermophilus) catalyses
RT   the formation of tyrosyl adenylate.";
RL   EMBO J. 2:1827-1829(1983).
RN   [4]
RP   INTERACTION WITH TRNA(TYR).
RX   PubMed=3006039; DOI=10.1073/pnas.83.5.1189;
RA   Carter P., Bedouelle H., Winter G.;
RT   "Construction of heterodimer tyrosyl-tRNA synthetase shows tRNATyr
RT   interacts with both subunits.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:1189-1192(1986).
RN   [5]
RP   MUTAGENESIS OF HIS-45; GLU-152; THR-224; LYS-410 AND LYS-411.
RX   PubMed=1542120; DOI=10.1016/0022-2836(92)90991-R;
RA   Vidal-Cros A., Bedouelle H.;
RT   "Role of residue Glu152 in the discrimination between transfer RNAs by
RT   tyrosyl-tRNA synthetase from Bacillus stearothermophilus.";
RL   J. Mol. Biol. 223:801-810(1992).
RN   [6]
RP   MUTAGENESIS OF LYS-230; PHE-231; GLY-232; LYS-233 AND THR-234.
RX   PubMed=10630994; DOI=10.1021/bi991675l;
RA   Xin Y., Li W., First E.A.;
RT   "The 'KMSKS' motif in tyrosyl-tRNA synthetase participates in the
RT   initial binding of tRNA(Tyr).";
RL   Biochemistry 39:340-347(2000).
RN   [7]
RP   MUTAGENESIS OF THR-40; HIS-45; HIS-48; LYS-82 AND ARG-86.
RX   PubMed=11023793; DOI=10.1006/jmbi.2000.4125;
RA   Xin Y., Li W., Dwyer D.S., First E.A.;
RT   "Correlating amino acid conservation with function in tyrosyl-tRNA
RT   synthetase.";
RL   J. Mol. Biol. 303:287-298(2000).
RN   [8]
RP   MUTAGENESIS OF ASP-78; TYR-169; GLN-173; ASP-194 AND GLN-195.
RX   PubMed=11023794; DOI=10.1006/jmbi.2000.4126;
RA   Xin Y., Li W., First E.A.;
RT   "Stabilization of the transition state for the transfer of tyrosine to
RT   tRNA(Tyr) by tyrosyl-tRNA synthetase.";
RL   J. Mol. Biol. 303:299-310(2000).
RN   [9]
RP   MUTAGENESIS OF LEU-322; PHE-323; SER-324; GLY-325 AND PHE-339.
RX   PubMed=11401566; DOI=10.1021/bi010208c;
RA   Gaillard C., Bedouelle H.;
RT   "An essential residue in the flexible peptide linking the two
RT   idiosynchratic domains of bacterial tyrosyl-tRNA synthetases.";
RL   Biochemistry 40:7192-7199(2001).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=7120416; DOI=10.1016/0022-2836(82)90255-8;
RA   Bhat T.N., Blow D.M., Brick P., Nyborg J.;
RT   "Tyrosyl-tRNA synthetase forms a mononucleotide-binding fold.";
RL   J. Mol. Biol. 158:699-709(1982).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   PubMed=2504923; DOI=10.1016/0022-2836(89)90090-9;
RA   Brick P., Bhat T.N., Blow D.M.;
RT   "Structure of tyrosyl-tRNA synthetase refined at 2.3-A resolution.
RT   Interaction of the enzyme with the tyrosyl adenylate intermediate.";
RL   J. Mol. Biol. 208:83-98(1989).
CC   -!- FUNCTION: Catalyzes the attachment of tyrosine to tRNA(Tyr) in a
CC       two-step reaction: tyrosine is first activated by ATP to form Tyr-
CC       AMP and then transferred to the acceptor end of tRNA(Tyr).
CC   -!- CATALYTIC ACTIVITY: ATP + L-tyrosine + tRNA(Tyr) = AMP +
CC       diphosphate + L-tyrosyl-tRNA(Tyr).
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.35 mM for ATP {ECO:0000269|PubMed:6315404};
CC         KM=1.8 uM for tyrosine {ECO:0000269|PubMed:6315404};
CC   -!- SUBUNIT: Homodimer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase
CC       family. TyrS type 1 subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 S4 RNA-binding domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J01546; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X04193; CAA27784.1; -; Genomic_DNA.
DR   PIR; A01179; SYBSYF.
DR   PDB; 1JH3; NMR; -; A=321-419.
DR   PDB; 1TYA; X-ray; 2.80 A; E=1-319.
DR   PDB; 1TYB; X-ray; 2.50 A; E=1-319.
DR   PDB; 1TYC; X-ray; 2.50 A; A=1-319.
DR   PDB; 1TYD; X-ray; 2.50 A; E=1-319.
DR   PDB; 2TS1; X-ray; 2.30 A; A=1-419.
DR   PDB; 3TS1; X-ray; 2.70 A; A=1-419.
DR   PDB; 4TS1; X-ray; 2.50 A; A/B=1-317.
DR   PDBsum; 1JH3; -.
DR   PDBsum; 1TYA; -.
DR   PDBsum; 1TYB; -.
DR   PDBsum; 1TYC; -.
DR   PDBsum; 1TYD; -.
DR   PDBsum; 2TS1; -.
DR   PDBsum; 3TS1; -.
DR   PDBsum; 4TS1; -.
DR   DisProt; DP00095; -.
DR   ProteinModelPortal; P00952; -.
DR   SMR; P00952; 1-319, 321-419.
DR   EvolutionaryTrace; P00952; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0004831; F:tyrosine-tRNA ligase activity; IEA:UniProtKB-HAMAP.
DR   GO; GO:0006437; P:tyrosyl-tRNA aminoacylation; IEA:UniProtKB-HAMAP.
DR   Gene3D; 3.10.290.10; -; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   HAMAP; MF_02006; Tyr_tRNA_synth_type1; 1.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR002305; aa-tRNA-synth_Ic.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR002942; S4_RNA-bd.
DR   InterPro; IPR002307; Tyr-tRNA-ligase.
DR   InterPro; IPR024088; Tyr-tRNA-ligase_bac-type.
DR   InterPro; IPR024107; Tyr-tRNA-ligase_bac_1.
DR   PANTHER; PTHR11766; PTHR11766; 1.
DR   Pfam; PF01479; S4; 1.
DR   Pfam; PF00579; tRNA-synt_1b; 1.
DR   PRINTS; PR01040; TRNASYNTHTYR.
DR   SMART; SM00363; S4; 1.
DR   TIGRFAMs; TIGR00234; tyrS; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
DR   PROSITE; PS50889; S4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm;
KW   Ligase; Nucleotide-binding; Protein biosynthesis; RNA-binding.
FT   CHAIN         1    419       Tyrosine--tRNA ligase.
FT                                /FTId=PRO_0000055642.
FT   DOMAIN      352    419       S4 RNA-binding.
FT   MOTIF        39     48       "HIGH" region.
FT   MOTIF       230    234       "KMSKS" region.
FT   BINDING      34     34       Tyrosine. {ECO:0000250}.
FT   BINDING     169    169       Tyrosine. {ECO:0000250}.
FT   BINDING     173    173       Tyrosine. {ECO:0000250}.
FT   BINDING     233    233       ATP. {ECO:0000250}.
FT   MUTAGEN      40     40       T->A: Destabilizes the transition states
FT                                for both steps of the reaction.
FT                                {ECO:0000269|PubMed:11023793}.
FT   MUTAGEN      45     45       H->A: Does not affect the second step of
FT                                the reaction.
FT                                {ECO:0000269|PubMed:11023793,
FT                                ECO:0000269|PubMed:1542120}.
FT   MUTAGEN      45     45       H->N: Decreases the rate of formation of
FT                                Tyr-AMP and, as a consequence, abolishes
FT                                the aminoacylation activity. Strongly
FT                                increases the toxicity; when associated
FT                                with A-152. {ECO:0000269|PubMed:11023793,
FT                                ECO:0000269|PubMed:1542120}.
FT   MUTAGEN      48     48       H->A: Does not affect the second step of
FT                                the reaction.
FT                                {ECO:0000269|PubMed:11023793}.
FT   MUTAGEN      78     78       D->A: Does not affect the initial binding
FT                                of tRNA(Tyr) and the stability of the
FT                                transition state for the second step of
FT                                the reaction.
FT                                {ECO:0000269|PubMed:11023794}.
FT   MUTAGEN      82     82       K->A: Destabilizes the transition states
FT                                for both steps of the reaction.
FT                                {ECO:0000269|PubMed:11023793}.
FT   MUTAGEN      86     86       R->A: Destabilizes the transition states
FT                                for both steps of the reaction.
FT                                {ECO:0000269|PubMed:11023793}.
FT   MUTAGEN     152    152       E->A: Mischarges tRNA(Phe) with tyrosine
FT                                in vitro. Toxic for the cell, probably
FT                                because it alters the discrimination of
FT                                TyrRS against non-cognate tRNAs. The
FT                                toxicity is abolished; when associated
FT                                with N-410 or N-411. Strongly increases
FT                                toxicity; when associated with N-45.
FT                                Enhances the toxicity; when associated
FT                                with A-224. {ECO:0000269|PubMed:1542120}.
FT   MUTAGEN     152    152       E->D: Does not charge tRNA(Phe) in vitro
FT                                with tyrosine.
FT                                {ECO:0000269|PubMed:1542120}.
FT   MUTAGEN     152    152       E->Q: Mischarges tRNA(Phe) with tyrosine
FT                                in vitro but this mutation is not toxic
FT                                in vivo. {ECO:0000269|PubMed:1542120}.
FT   MUTAGEN     169    169       Y->A: Does not affect the initial binding
FT                                of tRNA(Tyr) and the stability of the
FT                                transition state for the second step of
FT                                the reaction.
FT                                {ECO:0000269|PubMed:11023794}.
FT   MUTAGEN     173    173       Q->A: Destabilizes the transition state
FT                                for the second step of the reaction.
FT                                {ECO:0000269|PubMed:11023794}.
FT   MUTAGEN     194    194       D->A: Destabilizes the transition state
FT                                for the first step of the reaction, but
FT                                does not affect the transition state for
FT                                the second step.
FT                                {ECO:0000269|PubMed:11023794}.
FT   MUTAGEN     195    195       Q->A: Destabilizes the transition state
FT                                for the first step of the reaction, but
FT                                does not affect the transition state for
FT                                the second step.
FT                                {ECO:0000269|PubMed:11023794}.
FT   MUTAGEN     224    224       T->A: Is not toxic in itself. Enhances
FT                                the toxicity; when associated with A-152.
FT                                {ECO:0000269|PubMed:1542120}.
FT   MUTAGEN     230    230       K->A: Decreases the binding affinity
FT                                between tRNA(Tyr) and TyrRS-Tyr-AMP
FT                                complex. {ECO:0000269|PubMed:10630994}.
FT   MUTAGEN     231    231       F->L: No effect on the binding affinity
FT                                between tRNA(Tyr) and TyrRS-Tyr-AMP
FT                                complex. {ECO:0000269|PubMed:10630994}.
FT   MUTAGEN     232    232       G->A: No effect on the binding affinity
FT                                between tRNA(Tyr) and TyrRS-Tyr-AMP
FT                                complex. {ECO:0000269|PubMed:10630994}.
FT   MUTAGEN     233    233       K->A: Decreases the binding affinity
FT                                between tRNA(Tyr) and TyrRS-Tyr-AMP
FT                                complex. {ECO:0000269|PubMed:10630994}.
FT   MUTAGEN     234    234       T->A: No effect on the binding affinity
FT                                between tRNA(Tyr) and TyrRS-Tyr-AMP
FT                                complex. {ECO:0000269|PubMed:10630994}.
FT   MUTAGEN     322    322       L->P: 50-fold decrease in charging of
FT                                tRNA(Tyr) with tyrosine.
FT                                {ECO:0000269|PubMed:11401566}.
FT   MUTAGEN     323    323       F->A: 90-fold decrease in charging of
FT                                tRNA(Tyr) with tyrosine, without effect
FT                                on the first step of the reaction.
FT                                {ECO:0000269|PubMed:11401566}.
FT   MUTAGEN     323    323       F->L: 67-fold decrease in charging of
FT                                tRNA(Tyr) with tyrosine, without effect
FT                                on the first step of the reaction.
FT                                {ECO:0000269|PubMed:11401566}.
FT   MUTAGEN     323    323       F->W: Weak decrease in charging of
FT                                tRNA(Tyr) with tyrosine, without effect
FT                                on the first step of the reaction.
FT                                {ECO:0000269|PubMed:11401566}.
FT   MUTAGEN     323    323       F->Y: 3-fold decrease in charging of
FT                                tRNA(Tyr) with tyrosine, without effect
FT                                on the first step of the reaction.
FT                                {ECO:0000269|PubMed:11401566}.
FT   MUTAGEN     324    324       S->A: 2-fold increase in charging of
FT                                tRNA(Tyr) with tyrosine.
FT                                {ECO:0000269|PubMed:11401566}.
FT   MUTAGEN     325    325       G->A: 5-fold increase in charging of
FT                                tRNA(Tyr) with tyrosine.
FT                                {ECO:0000269|PubMed:11401566}.
FT   MUTAGEN     339    339       F->L: Has no effect on charging of
FT                                tRNA(Tyr) with tyrosine.
FT                                {ECO:0000269|PubMed:11401566}.
FT   MUTAGEN     410    410       K->N: Decreases the binding of tRNA(Tyr),
FT                                without affecting the formation of Tyr-
FT                                AMP. Abolishes the toxicity; when
FT                                associated with A-152.
FT                                {ECO:0000269|PubMed:1542120}.
FT   MUTAGEN     411    411       K->N: Decreases the binding of tRNA(Tyr),
FT                                without affecting the formation of Tyr-
FT                                AMP. Abolishes the toxicity; when
FT                                associated with A-152.
FT                                {ECO:0000269|PubMed:1542120}.
FT   HELIX         2     10       {ECO:0000244|PDB:2TS1}.
FT   STRAND       14     17       {ECO:0000244|PDB:2TS1}.
FT   HELIX        19     28       {ECO:0000244|PDB:2TS1}.
FT   STRAND       32     37       {ECO:0000244|PDB:2TS1}.
FT   STRAND       40     43       {ECO:0000244|PDB:2TS1}.
FT   HELIX        46     48       {ECO:0000244|PDB:2TS1}.
FT   HELIX        49     60       {ECO:0000244|PDB:2TS1}.
FT   STRAND       64     69       {ECO:0000244|PDB:2TS1}.
FT   HELIX        73     75       {ECO:0000244|PDB:2TS1}.
FT   HELIX        91    105       {ECO:0000244|PDB:2TS1}.
FT   HELIX       106    108       {ECO:0000244|PDB:1TYC}.
FT   STRAND      114    116       {ECO:0000244|PDB:2TS1}.
FT   STRAND      119    122       {ECO:0000244|PDB:2TS1}.
FT   HELIX       124    127       {ECO:0000244|PDB:2TS1}.
FT   HELIX       132    138       {ECO:0000244|PDB:2TS1}.
FT   HELIX       140    142       {ECO:0000244|PDB:2TS1}.
FT   HELIX       145    149       {ECO:0000244|PDB:2TS1}.
FT   HELIX       152    155       {ECO:0000244|PDB:2TS1}.
FT   TURN        156    160       {ECO:0000244|PDB:2TS1}.
FT   HELIX       164    184       {ECO:0000244|PDB:2TS1}.
FT   STRAND      186    192       {ECO:0000244|PDB:2TS1}.
FT   HELIX       193    195       {ECO:0000244|PDB:2TS1}.
FT   HELIX       196    210       {ECO:0000244|PDB:2TS1}.
FT   STRAND      216    220       {ECO:0000244|PDB:2TS1}.
FT   STRAND      235    238       {ECO:0000244|PDB:4TS1}.
FT   STRAND      240    242       {ECO:0000244|PDB:2TS1}.
FT   TURN        243    245       {ECO:0000244|PDB:2TS1}.
FT   HELIX       248    256       {ECO:0000244|PDB:2TS1}.
FT   HELIX       260    270       {ECO:0000244|PDB:2TS1}.
FT   HELIX       275    287       {ECO:0000244|PDB:2TS1}.
FT   TURN        289    291       {ECO:0000244|PDB:1TYB}.
FT   HELIX       293    307       {ECO:0000244|PDB:2TS1}.
FT   HELIX       309    318       {ECO:0000244|PDB:2TS1}.
FT   STRAND      325    327       {ECO:0000244|PDB:1JH3}.
FT   HELIX       332    339       {ECO:0000244|PDB:1JH3}.
FT   STRAND      344    347       {ECO:0000244|PDB:1JH3}.
FT   HELIX       354    361       {ECO:0000244|PDB:1JH3}.
FT   HELIX       367    375       {ECO:0000244|PDB:1JH3}.
FT   STRAND      379    381       {ECO:0000244|PDB:1JH3}.
FT   TURN        389    391       {ECO:0000244|PDB:1JH3}.
FT   TURN        396    398       {ECO:0000244|PDB:1JH3}.
FT   STRAND      399    408       {ECO:0000244|PDB:1JH3}.
FT   STRAND      413    418       {ECO:0000244|PDB:1JH3}.
SQ   SEQUENCE   419 AA;  47303 MW;  B9CB64AEEEE2010F CRC64;
     MDLLAELQWR GLVNQTTDED GLRKLLNEER VTLYCGFDPT ADSLHIGHLA TILTMRRFQQ
     AGHRPIALVG GATGLIGDPS GKKSERTLNA KETVEAWSAR IKEQLGRFLD FEADGNPAKI
     KNNYDWIGPL DVITFLRDVG KHFSVNYMMA KESVQSRIET GISFTEFSYM MLQAYDFLRL
     YETEGCRLQI GGSDQWGNIT AGLELIRKTK GEARAFGLTI PLVTKADGTK FGKTESGTIW
     LDKEKTSPYE FYQFWINTDD RDVIRYLKYF TFLSKEEIEA LEQELREAPE KRAAQKTLAE
     EVTKLVHGEE ALRQAIRISE ALFSGDIANL TAAEIEQGFK DVPSFVHEGG DVPLVELLVS
     AGISPSKRQA REDIQNGAIY VNGERLQDVG AILTAEHRLE GRFTVIRRGK KKYYLIRYA
//
